Nodular Regenerative Hyperplasia Secondary to Neoadjuvant Chemotherapy for Colorectal Liver Metastases

Liver resection is the only curative treatment for patients with colorectal liver metastases (CLMs). Neoadjuvant chemotherapy can improve resectability but has a potential harmful effect on the nontumorous liver. Patients with chemotherapy-induced hepatic injury undergoing liver surgery have higher...

Full description

Saved in:
Bibliographic Details
Main Authors: Maartje A. J. van den Broek, Steven W. M. Olde Damink, Ann Driessen, Cornelis H. C. Dejong, Marc H. A. Bemelmans
Format: Article
Language:English
Published: Wiley 2009-01-01
Series:Case Reports in Medicine
Online Access:http://dx.doi.org/10.1155/2009/457975
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832564146169708544
author Maartje A. J. van den Broek
Steven W. M. Olde Damink
Ann Driessen
Cornelis H. C. Dejong
Marc H. A. Bemelmans
author_facet Maartje A. J. van den Broek
Steven W. M. Olde Damink
Ann Driessen
Cornelis H. C. Dejong
Marc H. A. Bemelmans
author_sort Maartje A. J. van den Broek
collection DOAJ
description Liver resection is the only curative treatment for patients with colorectal liver metastases (CLMs). Neoadjuvant chemotherapy can improve resectability but has a potential harmful effect on the nontumorous liver. Patients with chemotherapy-induced hepatic injury undergoing liver surgery have higher risks of post-resectional morbidity. We present two cases of patients without pre-existent liver disease treated with oxaliplatin-based chemotherapy followed by surgical resection of their CLMs. Their intra-operative liver specimen showed morphologic abnormalities characteristic of nodular regenerative hyperplasia (NRH). NRH led to portal hypertension in both patients that resulted in deleterious post-resectional complications and death of one patient. Interestingly, the other patient underwent two repeat nonanatomic liver resections because of recurrent CLMs. The intra-operative liver specimen still showed signs of NRH and sinusoidal congestion, but the post-resectional courses were uneventful. Nevertheless, caution is recommended in patients with suspected NRH. Careful volumetric analysis should guide the operative strategy. When future remnant liver volume is regarded insufficient, portal vein embolization or restrictive surgery should be considered.
format Article
id doaj-art-c8bf6f45b90e43f1b83a6350aecf75c2
institution Kabale University
issn 1687-9627
1687-9635
language English
publishDate 2009-01-01
publisher Wiley
record_format Article
series Case Reports in Medicine
spelling doaj-art-c8bf6f45b90e43f1b83a6350aecf75c22025-02-03T01:11:47ZengWileyCase Reports in Medicine1687-96271687-96352009-01-01200910.1155/2009/457975457975Nodular Regenerative Hyperplasia Secondary to Neoadjuvant Chemotherapy for Colorectal Liver MetastasesMaartje A. J. van den Broek0Steven W. M. Olde Damink1Ann Driessen2Cornelis H. C. Dejong3Marc H. A. Bemelmans4Department of Surgery, Maastricht University Medical Centre, P.O. Box 5800, 6202 AZ Maastricht, The NetherlandsDepartment of Surgery, Maastricht University Medical Centre, P.O. Box 5800, 6202 AZ Maastricht, The NetherlandsDepartment of Pathology, Maastricht University Medical Centre, P.O. Box 5800, 6202 AZ Maastricht, The NetherlandsDepartment of Surgery, Maastricht University Medical Centre, P.O. Box 5800, 6202 AZ Maastricht, The NetherlandsDepartment of Surgery, Maastricht University Medical Centre, P.O. Box 5800, 6202 AZ Maastricht, The NetherlandsLiver resection is the only curative treatment for patients with colorectal liver metastases (CLMs). Neoadjuvant chemotherapy can improve resectability but has a potential harmful effect on the nontumorous liver. Patients with chemotherapy-induced hepatic injury undergoing liver surgery have higher risks of post-resectional morbidity. We present two cases of patients without pre-existent liver disease treated with oxaliplatin-based chemotherapy followed by surgical resection of their CLMs. Their intra-operative liver specimen showed morphologic abnormalities characteristic of nodular regenerative hyperplasia (NRH). NRH led to portal hypertension in both patients that resulted in deleterious post-resectional complications and death of one patient. Interestingly, the other patient underwent two repeat nonanatomic liver resections because of recurrent CLMs. The intra-operative liver specimen still showed signs of NRH and sinusoidal congestion, but the post-resectional courses were uneventful. Nevertheless, caution is recommended in patients with suspected NRH. Careful volumetric analysis should guide the operative strategy. When future remnant liver volume is regarded insufficient, portal vein embolization or restrictive surgery should be considered.http://dx.doi.org/10.1155/2009/457975
spellingShingle Maartje A. J. van den Broek
Steven W. M. Olde Damink
Ann Driessen
Cornelis H. C. Dejong
Marc H. A. Bemelmans
Nodular Regenerative Hyperplasia Secondary to Neoadjuvant Chemotherapy for Colorectal Liver Metastases
Case Reports in Medicine
title Nodular Regenerative Hyperplasia Secondary to Neoadjuvant Chemotherapy for Colorectal Liver Metastases
title_full Nodular Regenerative Hyperplasia Secondary to Neoadjuvant Chemotherapy for Colorectal Liver Metastases
title_fullStr Nodular Regenerative Hyperplasia Secondary to Neoadjuvant Chemotherapy for Colorectal Liver Metastases
title_full_unstemmed Nodular Regenerative Hyperplasia Secondary to Neoadjuvant Chemotherapy for Colorectal Liver Metastases
title_short Nodular Regenerative Hyperplasia Secondary to Neoadjuvant Chemotherapy for Colorectal Liver Metastases
title_sort nodular regenerative hyperplasia secondary to neoadjuvant chemotherapy for colorectal liver metastases
url http://dx.doi.org/10.1155/2009/457975
work_keys_str_mv AT maartjeajvandenbroek nodularregenerativehyperplasiasecondarytoneoadjuvantchemotherapyforcolorectallivermetastases
AT stevenwmoldedamink nodularregenerativehyperplasiasecondarytoneoadjuvantchemotherapyforcolorectallivermetastases
AT anndriessen nodularregenerativehyperplasiasecondarytoneoadjuvantchemotherapyforcolorectallivermetastases
AT cornelishcdejong nodularregenerativehyperplasiasecondarytoneoadjuvantchemotherapyforcolorectallivermetastases
AT marchabemelmans nodularregenerativehyperplasiasecondarytoneoadjuvantchemotherapyforcolorectallivermetastases